قالب وردپرس درنا توس
Home / Tag Archives: Novartis

Tag Archives: Novartis

Novartis will not raise US drug prices this year

Updated on July 18, 2018 10:05 AM ET Novartis AG will not increase its US drug prices for the remainder of 2018, said Swiss-based pharmaceutical companies on Wednesday, just days after Pfizer Inc. had taken a similar step following President Donald Trump's criticism. Novartis Chief Executive Vas Narasimhan said the company will evaluate its strategy for 2019 if it has …

Read More »

Novartis has a "longer and more detailed" relationship with Trump lawyer Michael Cohen, according to the Senate report

The relationship between Swiss pharmaceutical company Novartis AG and Michael Cohen, President Donald Trump's lawyer for many years, was "longer and more detailed" than the company said, a new report by the Senate Committee has found. Novartis NOVN, + 0.13% has said that a month after entering into a one-year, $ 1.2 million contract with Cohen's consulting firm, the relationship …

Read More »

Novartis will spin off Alcon's eye care business

Novartis AG announced Friday that it would spin off its Alcon eye care unit, a business analyst estimated at more than $ 20 billion, the company's new chief executive's latest move to transform the Swiss drug giant [196592002] Das Company said that the spin-off of Alcon into a separate business, publicly traded in Switzerland and the US, would allow the …

Read More »

Novartis will spin off Alcon and launch a $ 5 billion share buyback

Novartis plans to divest the Alcon eye care business to shareholders and repurchase up to $ 5 billion as CEO Vas Narasimhan restructures the Swiss group for prescription drugs. Alcon, a legacy of former Novartis boss Daniel Vasella Employment creation was problematic as it was bought in 2011 for $ 52 billion. Narasimhan declined to give a review on Friday …

Read More »

Novartis will launch Alcon's eye-care business

Updated on June 29, 2018 6:16 pm ET Novartis AG NVS 0.77% said on Friday that it would spin off its Alcon Eye Care unit, a business analyst thinks it could be estimated at more than $ 20 billion, the latest step the company's chief executive to transform the Swiss drug giant. The company said that the spin-off of Alcon …

Read More »

Novartis lawyer relies on Cohen payments

sixteenth May 2018 2:53 pm ET Novartis AG NVS -1.12% said Wednesday that his general counsel related to his payments of $ 1.2 million to a company owned by Michael Cohen, American President Donald Trumps longtime private lawyer, as the Swiss pharmaceutical manufacturer struggles to contain the consequences of the arrangement. Novartis paid $ 100,000 a month to Mr. Cohen's …

Read More »

Novartis Talks to Muller Cohen about His $ 1.2 Million Contract with Mueller's Office

Swiss pharmaceutical giant Novartis said Wednesday he spoke with lawyers for Special Adviser Robert S. Mueller III about payments to a shell company run by Michael D. Cohen, personal advocate and longtime fixer to President Trump, is controlled. 19659002] Novartis said it has paid $ 1.2 million to Mr. Cohen's company Essential Consultants LLC for a one-year health policy advisory …

Read More »